ALICIA HENSLEY: Open Payments
NPI 1346619715 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 14 payments from 8 companies in 2025. Trend: 2023 $561 · 2024 $1,041 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $68 |
| ABBVIE INC. | 3 | $66 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, OTEZLA, EVENITY, MOUNJARO, VRAYLAR, VYNDAQEL, Auvelity, YUPELRI.
Industry payments across IN — which companies pay providers there.
